Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fc receptor engagement
出版年份 2012 全文链接
标题
Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fc receptor engagement
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 27, Pages 10966-10971
出版商
Proceedings of the National Academy of Sciences
发表日期
2012-06-21
DOI
10.1073/pnas.1208698109
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel roles for the IgG Fc glycan
- (2012) Robert M. Anthony et al. Annals of the New York Academy of Sciences
- First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study
- (2012) George D. Demetri et al. EUROPEAN JOURNAL OF CANCER
- Mouse model recapitulating human Fc receptor structural and functional diversity
- (2012) P. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
- (2011) Nicholas S. Wilson et al. CANCER CELL
- Modulation of antibody effector function
- (2011) John R. Desjarlais et al. EXPERIMENTAL CELL RESEARCH
- Interaction with Fc RIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
- (2011) A. L. White et al. JOURNAL OF IMMUNOLOGY
- Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fc Receptor and Complement-Dependent Effector Mechanisms
- (2011) M. R. Vogt et al. JOURNAL OF VIROLOGY
- Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors
- (2011) Matthew E. Cohen et al. PLoS One
- Inhibitory Fc Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
- (2011) F. Li et al. SCIENCE
- Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
- (2010) Andres Forero-Torres et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors
- (2010) R. S. Herbst et al. CLINICAL CANCER RESEARCH
- A requirement for FcγR in antibody-mediated bacterial toxin neutralization
- (2010) Nareen Abboud et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD11c+ Dendritic Cells and B Cells Contribute to the Tumoricidal Activity of Anti-DR5 Antibody Therapy in Established Tumors
- (2010) N. M. Haynes et al. JOURNAL OF IMMUNOLOGY
- Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
- (2009) H. A. Wakelee et al. ANNALS OF ONCOLOGY
- Distinct cell-specific control of autoimmunity and infection by FcγRIIb
- (2008) Rebecca J. Brownlie et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
- (2008) Seung Y. Chu et al. MOLECULAR IMMUNOLOGY
- Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
- (2008) K. Takeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started